NCT04837365Completed
Impact of Neuropsychological Disorders in Multiple Sclerosis
Impact of Neuropsychological Disorders on Visual Exploration, Walking Initiation and Walking in Multiple Sclerosis
Source: ClinicalTrials.gov · Last updated 11 Mar 2026
Brief summary (registry, in English)
The study involves MS patients with and without neuropsychological disorders. The patient will benefit from: * A routine neuropsychological assessment, including a cognitive and emotional assessment * A clinical examination * A three-dimensional analysis of movement
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 32 (actual)
- First submitted
- 7 Apr 2021
- Start date
- 21 May 2021
- Primary completion date
- 7 Nov 2025
- Lead sponsor
- Lille Catholic University
- Diseases
- Multiple sclerosis
- NCT number
- NCT04837365
What you commit to
- Study type: Interventional
- Participants enrolled: 32
- From 21 May 2021 to the primary completion date, 7 Nov 2025
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- People with previous neurological pathologies, head trauma with loss of consciousness, psychiatric pathologies, serious general ailments, perceptual or dysarthric disorders preventing verbal communication or reading,
- Treatment with psychotropic drugs (except benzodiazepines and hypnotics).
Other
- Refusal to participate after clear and fair information about the study.
- Adults under tutorship, curatorship or safeguard of justice
- With orthopedic treatment influencing walking
- Pregnant woman
Who the study is looking for
- Understanding and able to speak French
- Carriers of MS with relapsing remitting form (RRMS-RR) with an EDSS \<4
- No significant motor, cerebellar or somesthesia disorders of the upper limbs or visual disturbances (side to a visual EDSS \<2)
- Absence of corticosteroid intake in the last four weeks
- Benefiting from health insurance coverage
- Not showing any flare-ups or worsening of the disease in the last 6 weeks
- No botulinum toxin injection for more than 4 months
Age in the registry: 18 years to 55 years · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| St Vincent hospital - neurological service Coordinator of this site? Confirm its status | Lille | France | Unknown status |
| St Philibert hospital - Physical Medicine and Rehabilitation Coordinator of this site? Confirm its status | Lomme | France | Unknown status |
| St Philibert hospital - Neurologial service Coordinator of this site? Confirm its status | Lomme | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.